{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:52:12Z","timestamp":1791863532291,"version":"4.3.4"},"reference-count":171,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Federal State Budgetary Institution \u201cResearch Institute of Pathology and Pathophysiology\u201d","award":["FGFU-2022-0011"],"award-info":[{"award-number":["FGFU-2022-0011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>One of the main causes of maternal and neonatal morbidity and mortality is pre-eclampsia. It is characterized by a high sFlt1\/PlGF ratio, according to prior research. Pregestational diseases in mothers may increase the risk of developing pre-eclampsia. Only a few studies have looked at the connection between maternal comorbidities before conception and the sFlt1\/PlGF ratio. The most recent information regarding the association between maternal pregestational diseases and the ratio of sFlt1\/PlGF is described in this review. The paper also examines current research suggesting that changes in pregnancy hormones and metabolites are related to a high sFlt1\/PlGF ratio. Certain maternal disorders have been found to dramatically raise sFlt-1 and sFlt1\/PlGF levels, according to an analysis of the literature. There is still debate about the data on the association between the sFlt1\/PlGF ratio and maternal disorders such as HIV, acute coronary syndromes, cardiovascular function in the mother between 19 and 23 weeks of pregnancy, thyroid hormones, diabetes, and cancer. Additional research is needed to confirm these findings.<\/jats:p>","DOI":"10.3390\/ijms24076744","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T02:11:41Z","timestamp":1680660701000},"page":"6744","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Literature Review: The sFlt1\/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia"],"prefix":"10.3390","volume":"24","author":[{"given":"Nataliia Sergeevna","family":"Karpova","sequence":"first","affiliation":[{"name":"Federal State Budgetary Institution \u201cResearch Institute of Pathology and Pathophysiology\u201d, St. Baltiyskaya, House 8, Moscow 125315, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2067-0971","authenticated-orcid":false,"given":"Olga Pavlovna","family":"Dmitrenko","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u201cResearch Institute of Pathology and Pathophysiology\u201d, St. Baltiyskaya, House 8, Moscow 125315, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana Sergeevna","family":"Budykina","sequence":"additional","affiliation":[{"name":"State Budgetary Health Institution of the Moscow Region \u201cMoscow Regional Research Institute of Obstetrics and Gynecology\u201d, St. Pokrovka, d.22a, Moscow 101000, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"(2020). Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet. Gynecol., 135, e237\u2013e260.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/IBPC.S77344","article-title":"Current best practice in the management of hypertensive disorders in pregnancy","volume":"9","author":"Khalil","year":"2016","journal-title":"Integr. Blood Press. Control"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"E323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: A WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kluivers, A.C.M., Biesbroek, A., Visser, W., Saleh, L., Russcher, H., Danser, J.A.H., and Neuman, R.I. (Ultrasound Obstet. Gynecol., 2022). Angiogenic imbalance in pre-eclampsia and fetal growth restriction: Enhanced soluble Fms-like tyrosine kinase-1 binding or diminished production of placental growth factor?, Ultrasound Obstet. Gynecol., ahead of print.","DOI":"10.1002\/uog.26088"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"165961","DOI":"10.1016\/j.bbadis.2020.165961","article-title":"Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia","volume":"1866","author":"Chiarello","year":"2020","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3389\/fimmu.2020.01864","article-title":"Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia","volume":"11","author":"Aneman","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3343\/alm.2018.38.2.95","article-title":"Evaluation of sFlt-1\/PlGF Ratio for Predicting and Improving Clinical Management of Pre-eclampsia: Experience in a Specialized Perinatal Care Center","volume":"38","author":"Caillon","year":"2018","journal-title":"Ann. Lab. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.placenta.2022.02.017","article-title":"Comparison of circulating total sFLT-1 to placental-specific sFLT-1 e15a in women with suspected preeclampsia","volume":"120","author":"Rowson","year":"2022","journal-title":"Placenta"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/08977199308991586","article-title":"A heparin-binding form of placenta growth factor (PLGF-2) is expressed in human umbilical vein endothelial cells and in placenta","volume":"9","author":"Hauser","year":"1993","journal-title":"Growth Factors"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/bbrc.1997.6813","article-title":"Placenta growth factor: Identification and characterization of a novel isoform generated by RNA alternative splicing","volume":"235","author":"Cao","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-0378(03)00082-2","article-title":"Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells","volume":"60","author":"Yang","year":"2003","journal-title":"J. Reprod. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"a011056","DOI":"10.1101\/cshperspect.a011056","article-title":"PlGF: A Multitasking Cytokine with Disease-Restricted Activity","volume":"2","author":"Dewerchin","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"Chau","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/00016340802253759","article-title":"Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia","volume":"87","author":"Baviera","year":"2008","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/14767058.2014.880882","article-title":"Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles","volume":"27","author":"Alahakoon","year":"2014","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/jog.13452","article-title":"Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and\/or fetal growth restriction","volume":"43","author":"Nanjo","year":"2017","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11906-017-0706-5","article-title":"Anti-angiogenesis and Preeclampsia in 2016","volume":"19","author":"Stepan","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e6005","DOI":"10.1097\/MD.0000000000006005","article-title":"Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes","volume":"96","year":"2017","journal-title":"Medicine"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Nikuei, P., Rajaei, M., Roozbeh, N., Mohseni, F., Poordarvishi, F., Azad, M., and Haidari, S. (2020). Diagnostic accuracy of sFlt1\/PlGF ratio as a marker for preeclampsia. BMC Pregnancy Childbirth, 20.","DOI":"10.1186\/s12884-020-2744-2"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Dathan-Stumpf, A., Rieger, A., Verlohren, S., Wolf, C., and Stepan, H. (2022). sFlt-1\/PlGF ratio for prediction of preeclampsia in clinical routine: A pragmatic real-world analysis of healthcare resource utilisation. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0263443"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.AOG.0000216014.72503.09","article-title":"Circulating angiogenic factors and placental abruption","volume":"108","author":"Signore","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jri.2015.07.004","article-title":"Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia","volume":"114","year":"2016","journal-title":"J. Reprod. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.preghy.2021.05.011","article-title":"Angiogenic factors and prediction for ischemic placental disease in future pregnancies","volume":"25","author":"Johnson","year":"2021","journal-title":"Pregnancy Hypertens."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/10641955.2014.926914","article-title":"Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia","volume":"33","author":"Baltajian","year":"2014","journal-title":"Hypertens. Pregnancy"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s13167-021-00258-x","article-title":"Early gestational profiling of oxidative stress and angiogenic growth mediators as predictive, preventive and personalised (3P) medical approach to identify suboptimal health pregnant mothers likely to develop preeclampsia","volume":"12","author":"Anto","year":"2021","journal-title":"EPMA J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.placenta.2004.05.004","article-title":"Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta","volume":"26","author":"Li","year":"2005","journal-title":"Placenta"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"799653","DOI":"10.3389\/fphys.2021.799653","article-title":"Serum From Preeclamptic Women Triggers Endoplasmic Reticulum Stress Pathway and Expression of Angiogenic Factors in Trophoblast Cells","volume":"12","author":"Castro","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"E1444","DOI":"10.1210\/jc.2011-0037","article-title":"Soluble FMS-like tyrosine kinase-1 (sFlt-1) and serum placental growth factor (PLGF) as biomarkers for ectopic pregnancy and missed abortion","volume":"96","author":"Daponte","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/pd.1869","article-title":"Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption","volume":"27","author":"Tikkanen","year":"2007","journal-title":"Prenat. Diagn."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/AOG.0000000000000367","article-title":"Characterization of the Soluble FMS-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction","volume":"124","author":"Herraiz","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/jog.14038","article-title":"Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers?","volume":"45","author":"Zhang","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.119.13763","article-title":"Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome","volume":"75","author":"Stepan","year":"2020","journal-title":"Hypertension"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fmed.2018.00325","article-title":"Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control Study","volume":"5","author":"Huhn","year":"2018","journal-title":"Front. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/10641955.2016.1237642","article-title":"Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia","volume":"36","author":"Tang","year":"2017","journal-title":"Hypertens. Pregnancy"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.preghy.2018.05.011","article-title":"The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia","volume":"13","author":"Cui","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"ref_37","first-page":"107","article-title":"Short Term Prediction of Preeclampsia","volume":"3","author":"Sroka","year":"2021","journal-title":"Matern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Stepan, H., Galindo, A., Hund, M., Schlembach, D., Sillman, J., Surbek, D., and Vatish, M. (Ultrasound Obstet. Gynecol., 2022). Clinical utility of sFlt -1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction, Ultrasound Obstet. Gynecol., ahead of print.","DOI":"10.1002\/uog.26032"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJMc1602338","article-title":"The sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Bolla","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1515\/cclm-2017-0443","article-title":"Use of the sFlt-1\/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?","volume":"56","author":"Ganuza","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20110097","article-title":"Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia","volume":"122","author":"Verlohren","year":"2012","journal-title":"Clin. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New Gestational Phase\u2013Specific Cutoff Values for the Use of the Soluble Fms-Like Tyrosine Kinase-1\/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: Implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/jpm-2013-0074","article-title":"The importance of repeated measurements of the sFlt-1\/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction","volume":"42","author":"Schoofs","year":"2014","journal-title":"J. P\u00e9rinat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/HYPERTENSIONAHA.120.15552","article-title":"Usefulness of the sFlt-1\/PlGF (Soluble fms-Like Tyrosine Kinase-1\/Placental Growth Factor) Ratio in Diagnosis or Misdiagnosis in Women With Clinical Diagnosis of Preeclampsia","volume":"76","year":"2020","journal-title":"Hypertension"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/humrep\/dew225","article-title":"Novel circulating placental markers prokineticin-1, soluble Fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage","volume":"31","author":"Jayasena","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1055\/s-0042-1744286","article-title":"Diagnosis and Management of Preeclampsia: Suggested Guidance on the Use of Biomarkers. Diagn\u00f3stico e tratamento da pr\u00e9-ecl\u00e2mpsia: Sugest\u00e3o para o uso adequado dos biomarcadores","volume":"44","author":"Costa","year":"2022","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejogrb.2019.10.021","article-title":"Angiogenic profiling in HELLP syndrome cases with or without hypertension and proteinuria","volume":"243","author":"Trottmann","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preghy.2012.11.001","article-title":"The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"3","author":"Tranquilli","year":"2013","journal-title":"Pregnancy Hypertens."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jri.2016.02.002","article-title":"Elevated systemic galectin-1 levels characterize HELLP syndrome","volume":"114","author":"Schnabel","year":"2016","journal-title":"J. Reprod. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jog.13786","article-title":"Markedly higher sFlt-1\/PlGF ratio in a woman with acute fatty liver of pregnancy compared with HELLP syndrome","volume":"45","author":"Suzuki","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-Based Map of the Human Proteome","volume":"347","author":"Fagerberg","year":"2015","journal-title":"Science"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"eabh2169","DOI":"10.1126\/sciadv.abh2169","article-title":"A single\u2013cell type transcriptomics map of human tissues","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_56","first-page":"24","article-title":"Recent advances in the diagnosis and management of pre-eclampsia","volume":"7","author":"Duhig","year":"2015","journal-title":"F1000Prime Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"337.e1","DOI":"10.1016\/j.ajog.2017.12.235","article-title":"Chronic hypertension: First-trimester blood pressure control and likelihood of severe hypertension, preeclampsia, and small for gestational age","volume":"218","author":"Nzelu","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/uog.17493","article-title":"Chronic hypertension and adverse pregnancy outcome: A cohort study","volume":"50","author":"Panaitescu","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"374.e1","DOI":"10.1016\/j.ajog.2019.10.101","article-title":"First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia","volume":"222","author":"Nzelu","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.111.181735","article-title":"Angiogenic factors in superimposed preeclampsia: A longitudinal study of women with chronic","volume":"59","author":"Perni","year":"2012","journal-title":"Hypertension"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/10641955.2015.1115063","article-title":"Preeclampsia and superimposed preeclampsia: The same disease? The role of angiogenic biomarkers","volume":"35","author":"Costa","year":"2016","journal-title":"Hypertens. Pregnancy"},{"key":"ref_63","unstructured":"World Health Organization (2023, January 24). Cardiovascular Diseases (CVDs). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jacc.2005.11.064","article-title":"Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction","volume":"47","author":"Iwama","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/eurheartj\/ehq429","article-title":"Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction","volume":"32","author":"Hochholzer","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e002115","DOI":"10.1161\/CIRCHEARTFAILURE.115.002115","article-title":"Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure","volume":"9","author":"Hammadah","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2217\/bmm-2018-0492","article-title":"Placenta growth factor and sFlt-1 as biomarkers in ischemic heart disease and heart failure: A review","volume":"13","author":"Draker","year":"2019","journal-title":"Biomark. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2169\/internalmedicine.52.9073","article-title":"An elevated ratio of placental growth factor to soluble FMS-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease","volume":"52","author":"Matsumoto","year":"2013","journal-title":"Intern. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/bmm.15.111","article-title":"Prognostic use of soluble fms-like tyrosine kinase-1 and placental growth factor in patients with coronary artery disease","volume":"10","author":"Sinning","year":"2016","journal-title":"Biomark. Med."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Poldervaart, J.M., R\u00f6ttger, E., Dekker, M.S., Zuithoff, N.P.A., Verheggen, P.W.H.M., De Vrey, E.A., Wildbergh, T.X., Hof, A.W.J.V., Mosterd, A., and Hoes, A.W. (2015). No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132000"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/2048872616684678","article-title":"Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score","volume":"7","author":"Klingenberg","year":"2018","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11886-010-0106-9","article-title":"Cardiac disease in pregnancy: Value of Echocardiography","volume":"12","author":"Tsiaras","year":"2010","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.110.162321","article-title":"Maternal cardiac dysfunction and remodeling in women with preeclampsia at term","volume":"57","author":"Melchiorre","year":"2011","journal-title":"Hypertension"},{"key":"ref_74","first-page":"31","article-title":"Structure, expression and receptor-binding properties of placenta growth factor (PlGF)","volume":"237","author":"Persico","year":"1999","journal-title":"Poxviruses"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cvr\/cvu018","article-title":"Pre-eclampsia and cardiovascular disease","volume":"101","author":"Chen","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/HYPERTENSIONAHA.120.15830","article-title":"Angiogenic Factors and Long-Term Cardiovascular Risk in Women That Developed Preeclampsia During Pregnancy","volume":"76","author":"Mendoza","year":"2020","journal-title":"Hypertension"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/uog.15981","article-title":"Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia","volume":"50","author":"Akhter","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/uog.23568","article-title":"Maternal cardiac function at 19\u201323 weeks\u2019 gestation in prediction of pre-eclampsia","volume":"57","author":"Gibbone","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Behrens, I., Basit, S., Lykke, J.A., Ranthe, M.F., Wohlfahrt, J., Bundgaard, H., Melbye, M., and Boyd, H.A. (2019). Hypertensive disorders of pregnancy and peripartum cardiomyopathy: A nationwide cohort study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0211857"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1253\/circj.CJ-16-1193","article-title":"Imbalanced Angiogenesis in Peripartum Cardiomyopathy\u2015Diagnostic Value of Placenta Growth Factor","volume":"81","author":"Mebazaa","year":"2017","journal-title":"Circ. J."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Ullmo, J., Cruz-Lemini, M., S\u00e1nchez-Garc\u00eda, O., Bos-Real, L., De La Llama, P.F., Calero, F., Dom\u00ednguez-Gallardo, C., Garrido-Gimenez, C., Trilla, C., and Carreras-Costa, F. (2021). Cardiac dysfunction and remodeling regulated by anti-angiogenic environment in patients with preeclampsia: The ANGIOCOR prospective cohort study protocol. BMC Pregnancy Childbirth, 21.","DOI":"10.1186\/s12884-021-04263-w"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bpobgyn.2019.09.005","article-title":"Pregnancy and rheumatoid arthritis","volume":"64","author":"Littlejohn","year":"2019","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s12276-020-0443-8","article-title":"Angiogenic cytokines can reflect the synovitis severity and treatment response to biologics in rheumatoid arthritis","volume":"52","author":"Kim","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/art.27425","article-title":"Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955-2007","volume":"62","author":"Myasoedova","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10067-022-06436-0","article-title":"Maternal and fetal outcomes in pregnant women with rheumatoid arthritis: A systematic review and meta-analysis","volume":"42","author":"Huang","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/rheumatology\/keab372","article-title":"The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: Impact of disease activity and sulfasalazine use","volume":"61","author":"Neuman","year":"2021","journal-title":"Rheumatology"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017). KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl., 7, 1\u201359.","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.semnephrol.2017.05.005","article-title":"Chronic Kidney Disease and Pregnancy","volume":"37","author":"Hladunewich","year":"2017","journal-title":"Semin. Nephrol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2018.06.006","article-title":"Renal Disorders in Pregnancy: Core Curriculum 2019","volume":"73","author":"Suarez","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1681\/ASN.2014050459","article-title":"Risk of Adverse Pregnancy Outcomes in Women with CKD","volume":"26","author":"Piccoli","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/ndt\/gfs573","article-title":"Pre-eclampsia or chronic kidney disease? The flow hypothesis","volume":"28","author":"Piccoli","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s40620-022-01299-9","article-title":"Clinical usefulness of angiogenic factors in women with chronic kidney disease and suspected superimposed preeclampsia","volume":"35","year":"2022","journal-title":"J. Nephrol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.preghy.2020.09.007","article-title":"Role of sFlt-1\/PIGF ratio and uterine Doppler in pregnancies with chronic kidney disease suspected with Pre-eclampsia or HELLP syndrome","volume":"22","author":"Karge","year":"2020","journal-title":"Pregnancy Hypertens."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ki.2012.348","article-title":"Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers","volume":"83","author":"Rolfo","year":"2013","journal-title":"Kidney Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"127083","DOI":"10.1155\/2015\/127083","article-title":"Is It Possible to Differentiate Chronic Kidney Disease and Preeclampsia by means of New and Old Biomarkers? A Prospective Study","volume":"2015","author":"Rolfo","year":"2015","journal-title":"Dis. Markers"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/GRF.0000000000000494","article-title":"Acute Fatty Liver of Pregnancy","volume":"63","author":"Nelson","year":"2020","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/a-1091-8630","article-title":"HELLP Syndrome or Acute Fatty Liver of Pregnancy: A Differential Diagnostic Challenge: Common Features and Differences","volume":"80","author":"Rath","year":"2020","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/aogs.14218","article-title":"Soluble fms-like tyrosine kinase 1 (sFlt-1): A novel biochemical marker for acute fatty liver of pregnancy","volume":"100","author":"Trottmann","year":"2021","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_100","unstructured":"World Health Organization (2023, January 24). World Health Organization (WHO). Available online: https:\/\/www.who.int\/."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/AOG.0000000000000591","article-title":"Risk of adverse pregnancy outcomes by prepregnancy body mass index: A population-based study to inform prepregnancy weight loss counseling","volume":"125","author":"Schummers","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.ajog.2006.04.003","article-title":"Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia","volume":"195","author":"Suwaki","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"247.e1","DOI":"10.1016\/j.ajog.2014.03.020","article-title":"The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies","volume":"211","author":"Zera","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41366-018-0217-8","article-title":"Impact of obesity on angiogenic and inflammatory markers in the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC) cohort","volume":"43","author":"Finnpec","year":"2019","journal-title":"Int. J. Obes."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.preghy.2020.04.004","article-title":"Angiogenic factor abnormalities and risk of peripartum complications and prematurity among urban predominantly obese parturients with chronic hypertension","volume":"20","author":"Heimberger","year":"2020","journal-title":"Pregnancy Hypertens."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"100614","DOI":"10.1016\/j.ajogmf.2022.100614","article-title":"High early pregnancy body mass index is associated with alterations in first and second trimester angiogenic biomarkers","volume":"4","author":"Beck","year":"2022","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Karge, A., Desing, L., Haller, B., Ortiz, J.U., Lobmaier, S.M., Kuschel, B., and Graupner, O. (2022). Performance of sFlt-1\/PIGF Ratio for the Prediction of Perinatal Outcome in Obese Pre-Eclamptic Women. J. Clin. Med., 11.","DOI":"10.3390\/jcm11113023"},{"key":"ref_108","unstructured":"World Health Organization (2023, January 24). Obesity and Overweight. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bpobgyn.2014.09.008","article-title":"Metabolic disorder of pregnancy (understanding pathophysiology of diabetes and preeclampsia)","volume":"29","author":"Salzer","year":"2015","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fendo.2013.00037","article-title":"Beta cell dysfunction and insulin resistance","volume":"4","author":"Cerf","year":"2013","journal-title":"Front. Endocrinol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"831297","DOI":"10.3389\/fcvm.2022.831297","article-title":"Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors","volume":"9","author":"Yang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11892-015-0579-4","article-title":"Preeclampsia and diabetes","volume":"15","author":"Weissgerber","year":"2015","journal-title":"Curr. Diabetes Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-2007-994754","article-title":"Outcome of Pregnancies complicated by type 1 insulin-dependent diabetes in Sweden: Acute pregnancy complications, neonatal mortality and morbidity","volume":"10","author":"Hanson","year":"1993","journal-title":"Am. J. Perinatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2337\/dc17-0391","article-title":"The Association of Falling Insulin Requirements With Maternal Biomarkers and Placental Dysfunction: A Prospective Study of Women With Preexisting Diabetes in Pregnancy","volume":"40","author":"Padmanabhan","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejogrb.2014.07.018","article-title":"Predictive value of combined serum biomarkers for adverse pregnancy outcomes","volume":"181","author":"Cohen","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2337\/dc19-0967","article-title":"Urinary and Serum Angiogenic Markers in Women With Preexisting Diabetes During Pregnancy and Their Role in Preeclampsia Prediction","volume":"43","author":"Zen","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00125-008-1182-x","article-title":"Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women","volume":"52","author":"Yu","year":"2009","journal-title":"Diabetologia"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.2337\/dc13-0944","article-title":"The role of angiogenic and antiangiogenic factors in the second trimester in the prediction of preeclampsia in pregnant women with type 1 Diabetes","volume":"36","author":"Holmes","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/s41598-021-81785-5","article-title":"Placental and maternal sFlt1\/PlGF expression in gestational diabetes mellitus","volume":"11","author":"Nuzzo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/humrep\/dey364","article-title":"Early pregnancy bisphenol and phthalate metabolite levels, maternal hemodynamics and gestational hypertensive disorders","volume":"34","author":"Philips","year":"2019","journal-title":"Hum. Reprod."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2632637","DOI":"10.1155\/2018\/2632637","article-title":"Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns","volume":"2018","author":"Portelli","year":"2018","journal-title":"J. Pregnancy"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/10641950802419895","article-title":"Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria","volume":"28","author":"Ohkuchi","year":"2009","journal-title":"Hypertens. Pregnancy"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Abascal-Saiz, A., Duque-Alcorta, M., Fioravantti, V., Antol\u00edn, E., Fuente-Luelmo, E., Haro, M., Ramos-\u00c1lvarez, M.P., Perdomo, G., and Bartha, J.L. (2022). The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia. Nutrients, 14.","DOI":"10.3390\/nu14102172"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1477-7827-8-135","article-title":"Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: An in vitro study","volume":"8","author":"Anton","year":"2010","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Rana, S., Cerdeira, A.S., Wenger, J., Salahuddin, S., Lim, K.-H., Ralston, S.J., Thadhani, R.I., and Karumanchi, S.A. (2012). Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048259"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/10641955.2022.2066119","article-title":"Soluble endoglin versus sFlt-1\/PlGF ratio: Detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort","volume":"41","author":"Iannaccone","year":"2022","journal-title":"Hypertens. Pregnancy"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e13041","DOI":"10.1111\/aji.13041","article-title":"Humoral immunity in late-onset Pre-eclampsia and linkage with angiogenic and inflammatory markers","volume":"80","author":"Sarween","year":"2018","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1701-2163(15)30511-9","article-title":"Altered hemodynamics and hyperuricemia accompany an elevated sFlt-1\/PLGF ratio before the onset of early severe preeclampsia","volume":"36","author":"Doherty","year":"2014","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/hr.2014.71","article-title":"A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia","volume":"37","author":"Sahay","year":"2014","journal-title":"Hypertens. Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e0007","DOI":"10.5041\/RMMJ.10464","article-title":"COVID-19 and Preeclampsia: Overlapping Features in Pregnancy","volume":"13","author":"Sathiya","year":"2022","journal-title":"Rambam Maimonides Med. J."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Giardini, V., Ornaghi, S., Gambacorti-Passerini, C., Casati, M., Carrer, A., Acampora, E., Vasarri, M.V., Arienti, F., and Vergani, P. (2022). Imbalanced Angiogenesis in Pregnancies Complicated by SARS-CoV-2 Infection. Viruses, 14.","DOI":"10.3390\/v14102207"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.preghy.2021.12.001","article-title":"sFlt-1\/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19","volume":"27","author":"Soldavini","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/uog.24798","article-title":"Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19","volume":"59","author":"Poon","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11906-021-01126-9","article-title":"The COVID-19 Pandemic: An Appraisal of its Impact on Human Immunodeficiency Virus Infection and Pre-Eclampsia","volume":"23","author":"Govender","year":"2021","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Masi\u00e1, M., Padilla, S., Fern\u00e1ndez, M., Rodr\u00edguez, C., Moreno, A., Oteo, J.A., Antela, A., Moreno, S., del Amo, J., and Guti\u00e9rrez, F. (2016). Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153456"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"H1373","DOI":"10.1152\/ajpheart.00304.2005","article-title":"AIDS-related vasculopathy: Evidence for oxidative and inflammatory pathways in murine and human AIDS","volume":"289","author":"Baliga","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fcvm.2018.00185","article-title":"HIV Proteins and Endothelial Dysfunction: Implications in Cardiovascular Disease","volume":"5","author":"Anand","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2013.05.021","article-title":"Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia","volume":"170","author":"Govender","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0000000000001424","article-title":"Risk of Preeclampsia in Human Immunodeficiency Virus\u2013Infected Pregnant Women","volume":"127","author":"Sansone","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5830\/CVJA-2012-078","article-title":"Is the prevalence of pre-eclampsia affected by HIV\/AIDS? A retrospective case-control study: Cardiovascular topics","volume":"24","author":"Kalumba","year":"2013","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"29","DOI":"10.54548\/njps.v36i2.4","article-title":"Does HAART dysregulate angiogenesis in HIV infected preeclampsia?","volume":"37","author":"Padayachee","year":"2022","journal-title":"Niger. J. Physiol. Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2213-8587(22)00007-9","article-title":"Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: A systematic review and individual-participant data meta-analysis","volume":"10","author":"Toloza","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"b4336","DOI":"10.1136\/bmj.b4336","article-title":"Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: Nested case-control and population based study","volume":"339","author":"Levine","year":"2009","journal-title":"BMJ"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"E1328","DOI":"10.1210\/jc.2015-2553","article-title":"Placental Angiogenic Factors Are Associated With Maternal Thyroid Function and Modify hCG-Mediated FT4 Stimulation","volume":"100","author":"Korevaar","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Almasi-Hashiani, A., Omani-Samani, R., Mohammadi, M., Amini, P., Navid, B., Alizadeh, A., Morasae, E.K., and Maroufizadeh, S. (2019). Assisted reproductive technology and the risk of preeclampsia: An updated systematic review and meta-analysis. BMC Pregnancy Childbirth, 19.","DOI":"10.1186\/s12884-019-2291-x"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/HYPERTENSIONAHA.118.12043","article-title":"Increased Preeclampsia Risk and Reduced Aortic Compliance With In Vitro Fertilization Cycles in the Absence of a Corpus Luteum","volume":"73","author":"Schaub","year":"2019","journal-title":"Hypertension"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1439-0531.2004.00509.x","article-title":"Regulation of corpus luteum function in cattle\u2014An overview","volume":"39","author":"Schams","year":"2004","journal-title":"Reprod. Domest. Anim."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1152\/ajpregu.00239.2012","article-title":"Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies","volume":"304","author":"Conrad","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"212.e1","DOI":"10.1016\/j.ajog.2015.03.032","article-title":"Angiogenic markers in pregnancies conceived through in vitro fertilization","volume":"213","author":"Lee","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1477-7827-9-112","article-title":"Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF","volume":"9","author":"Biasoni","year":"2011","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10815-013-0144-5","article-title":"Ovarian sensitivity index is a better measure of ovarian responsiveness to gonadotrophin stimulation than the number of oocytes during in-vitro fertilization treatment","volume":"31","author":"Li","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40618-016-0550-5","article-title":"Follicular fluid PlGF\/sFlt-1 ratio and soluble receptor for advanced glycation end\u2013products correlate with ovarian sensitivity index in women undergoing A.R.T.","volume":"40","author":"Nejabati","year":"2017","journal-title":"J. Endocrinol. Investig."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/oxfordjournals.aje.a009022","article-title":"Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy","volume":"144","author":"Ananth","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Rasmussen, S., and Irgens, L.M. (2006). The effects of smoking and hypertensive disorders on fetal growth. BMC Pregnancy Childbirth, 6.","DOI":"10.1186\/1471-2393-6-16"},{"key":"ref_156","unstructured":"Owing, J.H. (2005). Trends in smoking and Health Research, Nova Biomedical Books."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/10641955.2012.704107","article-title":"Smoking during Pregnancy: Changes in mid-gestation angiogenic factors in women at risk of developing preeclampsia according to uterine artery Doppler findings","volume":"32","author":"Llurba","year":"2013","journal-title":"Hypertens. Pregnancy"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ajh.2008.219","article-title":"Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia","volume":"21","author":"Jeyabalan","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/ijc.31174","article-title":"Tumor characteristics and prognosis in women with pregnancy-associated breast cancer","volume":"142","author":"Johansson","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.2008.17.4110","article-title":"Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: A registry-based cohort study","volume":"27","author":"Stensheim","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncr.11929","article-title":"Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence","volume":"100","author":"Blakely","year":"2004","journal-title":"Cancer"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"153956","DOI":"10.1016\/j.prp.2022.153956","article-title":"Role of anti-angiogenic factors in the pathogenesis of breast cancer: A review of therapeutic potential","volume":"236","author":"Ruan","year":"2022","journal-title":"Pathol.-Res. Pract."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.semcancer.2015.01.001","article-title":"Broad targeting of angiogenesis for cancer prevention and therapy","volume":"35","author":"Wang","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10552-018-1100-6","article-title":"Maternal reproductive hormones and angiogenic factors in pregnancy and subsequent breast cancer risk","volume":"30","author":"Cornish","year":"2019","journal-title":"Cancer Causes Control"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00001648-199911000-00013","article-title":"Preeclampsia and Breast Cancer Risk","volume":"10","author":"Innes","year":"1999","journal-title":"Epidemiology"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-510X(98)00147-6","article-title":"Cerebral hemodynamics in young hypertensive subjects and effects of atenolol treatment","volume":"159","author":"Troisi","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"ref_167","first-page":"2525","article-title":"Fostervekst, preeklampsi og fremtidig brystkreftrisiko [Fetal growth, pre-eclampsia and adult breast cancer risk]","volume":"122","author":"Nilsen","year":"2002","journal-title":"Tidsskr. Nor. Laegeforen."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1080\/14767058.2018.1560406","article-title":"Risk of preeclampsia following assisted reproductive technology: Systematic review and meta-analysis of 72 cohort studies","volume":"33","author":"Alizadeh","year":"2020","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10552-016-0779-5","article-title":"A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"27","author":"Falk","year":"2016","journal-title":"Cancer Causes Control"},{"key":"ref_170","unstructured":"PDQ Adult Treatment Editorial Board (2022, November 24). Breast Cancer Treatment During Pregnancy (PDQ\u00ae): Patient Version, Available online: https:\/\/www.cancer.gov\/types\/breast\/patient\/pregnancy-breast-treatment-pdq."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Saura, C., S\u00e1nchez, O., Mart\u00ednez, S., Dom\u00ednguez, C., Dienstmann, R., Ru\u00edz-Pace, F., C\u00e9spedes, M.C., Pe\u00f1uelas, \u00c1., Cort\u00e9s, J., and Llurba, E. (2021). Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy. Cancers, 13.","DOI":"10.3390\/cancers13040923"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6744\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:10:04Z","timestamp":1760123404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":171,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ijms24076744"],"URL":"https:\/\/doi.org\/10.3390\/ijms24076744","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]}}}